PGEN
Precigen Inc
Price:  
1.32 
USD
Volume:  
1,415,997.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PGEN EV/EBITDA

-502.7%
Upside

As of 2025-06-01, the EV/EBITDA ratio of Precigen Inc (PGEN) is -3.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PGEN's latest enterprise value is 383.58 mil USD. PGEN's TTM EBITDA according to its financial statements is -116.25 mil USD. Dividing these 2 quantities gives us the above PGEN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.8x - 13.5x 12.4x
Forward P/E multiples 12.0x - 17.5x 14.6x
Fair Price (4.72) - (5.31) (5.32)
Upside -457.7% - -502.4% -502.7%
1.32 USD
Stock Price
(5.32) USD
Fair Price

PGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-23 -3.43
2025-05-22 -3.48
2025-05-21 -3.30
2025-05-20 -3.53
2025-05-19 -3.40
2025-05-16 -3.63
2025-05-15 -3.27
2025-05-14 -3.20
2025-05-13 -3.38
2025-05-12 -3.43
2025-05-09 -3.32
2025-05-08 -3.38
2025-05-07 -3.38
2025-05-06 -3.49
2025-05-05 -3.81
2025-05-02 -3.93
2025-05-01 -3.88
2025-04-30 -3.91
2025-04-29 -3.86
2025-04-28 -3.88
2025-04-25 -3.76
2025-04-24 -3.99
2025-04-23 -4.06
2025-04-22 -3.83
2025-04-21 -3.43
2025-04-17 -3.48
2025-04-16 -3.43
2025-04-15 -3.60
2025-04-14 -3.50
2025-04-11 -3.50
2025-04-10 -3.20
2025-04-09 -3.48
2025-04-08 -2.92
2025-04-07 -3.32
2025-04-04 -3.10
2025-04-03 -3.35
2025-04-02 -3.71
2025-04-01 -3.59
2025-03-31 -3.73
2025-03-28 -3.99
2025-03-27 -4.11
2025-03-26 -4.04
2025-03-25 -4.29
2025-03-24 -4.57
2025-03-21 -4.54
2025-03-20 -4.52
2025-03-19 -4.49
2025-03-18 -4.19
2025-03-17 -4.47
2025-03-14 -4.52